Activist shareholders continue to be closely-monitored and imitated by investors, given their ability to affect positive change at companies. Whether it be by pressuring companies to set loose underperforming divisions, pushing for change on the company’s Board, or advocating for more of the company’s profits to be distributed to shareholders in the form of share buybacks and/or dividend payments, activist investors know how to move the needle in the right direction. Embedded below and on the following pages is the latest 13D activist filing issued by Fountainhead Capital Management Ltd, in relation to its position in Vycor Medical Inc (OTCMKTS:VYCO). Check it out to see the investor’s latest ownership stake in the stock, which amounts to nearly 70% of the issuer’s series D convertible stock.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name || Sole Voting Power || Shared Voting Power || Sole Dispositive Power || Shared Dispositive Power || Aggregate Amount Owned Power || Percent of Class |
|Fountainhead Capital Management Limited || 181,994 || 0 || 181,994 || 0 || 181,994 || 69.68% |
Page 1 of 4 SEC Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
VYCOR MEDICAL, INC.
(Name of Issuer)
7% SERIES D CONVERTIBLE REDEEMABLE PREFERRED STOCK, PAR VALUE $0.0001
(Title of Class of Securities)
Fountainhead Capital Management Limited
1 Portman House, Hue Street
St. Helier, Jersey, Channel Islands JE4 5RP
+44 (0)1534 630112
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
February 5, 2016
(Date of Event which Requires Filing Statement on Schedule 13D)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ¨.